# The Direct III Post Market Study

> **NCT02693158** · — · COMPLETED · sponsor: **Svelte Medical Systems, Inc.** · enrollment: 440 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02693158
- **Lead sponsor:** Svelte Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-01
- **Final completion:** 2020-01
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02693158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02693158, "The Direct III Post Market Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02693158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*